β2-Adrenergic receptor polymorphism and nitric oxide-dependent forearm blood flow responses to isoproterenol in humans

Journal of Physiology

Volumn 546, Issue 2, 2003, Pages 583-589

  Garovic, Vesna D ^a   Joyner, Michael J ^a   Dietz, Niki M ^a   Boerwinkle, Eric ^b   Turner, Stephen T ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGININE; BETA 2 ADRENERGIC RECEPTOR; GLYCINE; ISOPRENALINE; N(G) METHYLARGININE; NITRIC OXIDE; ARGININE 16; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; GLYCINE 16; NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG;

ADULT; ARTERY DILATATION; ARTERY ENDOTHELIUM; BLOOD PRESSURE MEASUREMENT; BRACHIAL ARTERY; CAUCASIAN; CONTROLLED STUDY; DOWN REGULATION; DRUG RESPONSE; ENZYME INHIBITION; FEMALE; FOREARM BLOOD FLOW; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; IN VITRO STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STATISTICAL ANALYSIS; ARTICLE; BODY MASS; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; GENETIC CODE; HEART RATE; HOMOZYGOTE; IN VIVO STUDY; SYSTOLIC BLOOD PRESSURE; VEIN OCCLUSION PLETHYSMOGRAPHY; WAIST HIP RATIO;

ADRENERGIC BETA-AGONISTS; ADULT; AMINO ACID SUBSTITUTION; ARGININE; FEMALE; FOREARM; GLYCINE; HOMOZYGOTE; HUMANS; ISOPROTERENOL; MALE; NITRIC OXIDE; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-2; REGIONAL BLOOD FLOW;

EID: 12244265520     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2002.031138     Document Type: Review

References (32)

1. Bengtsson K, Orho-Melander M, Melander O, Lindblad U, Ranstam J, Rastam L & Groop L (200 1). β2-Adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes. Hypertension 37, 1303-1308.
2. Bray MS, Krushkal J, Li L, Ferrell R, Kardia S, Sing CF, Turner ST & Boerwinkle E (2000). Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation 101, 2877-2882.
3. Candy G, Samani N, Norton G, Woodiwiss A, Radevski I, Wheatley A, Cockcroft J & Hall IP (2000). Association analysis of beta2 adrenoceptor polymorphisms with hypertension in a Black African population. J Hypertens 18, 167-172.
4. Cockcroft JR, Gazis AG, Cross DJ, Wheatley A, Dewar J, Hall IP & Noon JP (2000). Beta(2)-adrenoceptor polymorphism determines vascular reactivity in humans. Hypertension 36, 371-375.
5. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ & Cooke JP (1992). L-arginine improves en dothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 90, 1248-1253.
6. Dawes M, Chowienczyk PJ & Ritter JM (1997). Effects of inhibition of the L-arginine/nitric oxide pathway on vasodilation caused by beta-adrenergic agonists in human forearm. Circulation 95, 2293-2297.
7. Dietz NM, Rivera JM, Eggener SE, Fix RT, Warner DO & Joyner MJ (1994). Nitric oxide contributes to the rise in forearm blood flow during mental stress in humans. J Physiol 480, 361-368.
8. Dishy V, Sofowora GG, Xie HG, Kim RB, Byrne DW, Stein CM & Wood AJ (2001). The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med 345, 1030-1035.
9. Drysdale CM, McGraw DW, Stack CB, Stephens JC, Judson RS, Nandabalan K, Arnold K, Ruano G & Liggett SB (2000). Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A 97, 10483-10488.
10. Engelke KA, Halliwill JR, Proctor DN, Dietz NM & Joyner MJ (1996). Contribution of nitric oxide and prostaglandins to reactive hyperemia in human forearm. J Appl Physiol 81, 1807-1814.
11. Feldman RD (1987). Beta-adrenergic receptor alterations in hypertension - physiological and molecular correlates. Can J Physiol Pharmacol 65, 1666-1672.
12. Feldman RD, Limbird LE, Nadeau J, Robertson D & Wood AJ (1984). Leukocyte beta-receptor alterations in hypertensive subjects. J Clin Invest 73, 648-653.
13. Gratze G, Fortin J, Labugger R, Binder A, Kotanko P, Timmermann B, Luft FC, Hoehe M R & Skrabal F (1999). Beta-2 adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians. Hypertension 33, 1425-1430.
14. Green SA, Cole G, Jacinto M, Innis M & Liggett SB (1993). A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J Biol Chem 268, 23116-23121.
15. Green SA, Turki J, Innis M & Liggett SB (1994). Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 33, 9414-9419.
16. Greenfield ADM, Whitney RJ & Mowbray JF (1963). Methods for the investigation of peripheral blood flow. Br Med Bull 19, 101-109.
17. Herrmann V, Buscher R, Go MM, Ring KM, Hofer JK, Kailasam MT, O'Connor DT, Parmer RJ & Insel PA (2000). Beta2-adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in whites and African Americans. Am J Hypertens 13, 1021-1026.
18. Hoit BD, Suresh DP, Craft L, Walsh RA & Liggett SB (2000). Beta2-adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals. Am Heart J 139, 537-542.
19. Jia H, Sharma P, Hopper R, Dickerson C, Lloyd DD & Brown MJ (2000). Beta2-adrenoceptor gene polymorphisms and blood pressure variations in East Anglian Caucasians. J Hypertens 18, 687-693.
20. Kato N, Sugiyama T, Morita H, Kurihara H, Sato T, Yamori Y & Yazaki Y (2001). Association analysis of beta (2)-adrenergic receptor polymorphisms with hypertension in Japanese. Hypertension 37, 286-292.
21. Kotanko P, Binder A, Tasker J, Defreitas P, Kamdar S, Clark AJ, Skrabal F & Caulfield M (1997). Essential hypertension in African Caribbean associates with a variant of the beta2-adrenoceptor. Hypertension 30, 773-776.
22. Krushkal J, Ferrell R, Mockrin SC, Turner ST, Sing CF & Boerwinkle E (1999). Genome-wide linkage analyses of systolic blood pressure using highly discordant siblings. Circulation 99, 1407-1410.
23. Krushkal J, Xiong M, Ferrell R, Sing CF, Turner ST & Boerwinkle E (1998). Linkage and association of adrenergic and dopamine receptor genes in the distal portion of the long arm of chromosome 5 with systolic blood pressure variation. Hum Mol Genet 7, 1379-1383.
24. Lang CC, Stein CM, Brown RM, Deegan R, Nelson R, He HB, Wood M & Wood AJ (1995). Attenuation of isoproterenol-mediated vasodilatation in blacks. N Engl J Med 333, 155-160.
25. Oates JA & Brown NJ (2001). Antihypertensive agents and the drug therapy of hypertension. In The Pharmacological Basis of Therapeutics, ed. Hardman JG, Limbird LE & Gilman AG, pp 871-900. McGraw-Hill, New York.
26. Panza JA, Casino PR, Kilcoyne CM & Quyyumi AA (1993). Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 87, 1468-1474.
27. Reihsaus E, Innis M, MacIntyre N & Liggett SB (1993). Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 8, 334-339.
28. Stein C, Nelson R, Deegan R, He H, Wood M & Wood A (1995). Forearm beta adrenergic receptor-mediated vasodilation is impaired, without alteration of forearm norepinephrine spillover, in borderline hypertension. J Clin Invest 96, 579-585.
29. Svetkey LP, Timmons PZ, Emovon O, Anderson NB, Preis L & Chen YT (1996). Association of hypertension with beta2- and alpha2c10-adrenergic receptor genotype. Hypertension 27, 1210-1215.
30. Taddei S, Virdis A, Mattei P, Ghiadoni L, Sudano I & Salvetti A (1996). Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation 94, 1298-1303.
31. Timmermann B, Mo R, Luft FC, Gerdts E, Busjahn A, Omvik P, Li GH, Schuster H, Wienker TF, Hoehe MR & Lund-Johansen P (1998). Beta-2 adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressure Study. Kidney Int 53, 1455-1460.
32. Xie HG, Stein CM, Kim RB, Gainer JV, Sofowora G, Dishy V, Brown NJ, Goree RE, Haines JL & Wood AJ (2000). Human beta2-adrenergic receptor polymorphisms: no association with essential hypertension in black or white Americans. Clin Pharmacol Ther 67,